Identification of novel functional inhibitors of acid sphingomyelinase.
We describe a hitherto unknown feature for 27 small drug-like molecules, namely functional inhibition of acid sphingomyelinase (ASM). These entities named FIASMAs (Functional Inhibitors of Acid SphingoMyelinAse), therefore, can be potentially used to treat diseases associated with enhanced activity...
Guardado en:
Autores principales: | Johannes Kornhuber, Markus Muehlbacher, Stefan Trapp, Stefanie Pechmann, Astrid Friedl, Martin Reichel, Christiane Mühle, Lothar Terfloth, Teja W Groemer, Gudrun M Spitzer, Klaus R Liedl, Erich Gulbins, Philipp Tripal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd25bf066ec3473fbd19d8571dd669db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.
por: Christiane Mühle, et al.
Publicado: (2013) -
Functional implications of novel human acid sphingomyelinase splice variants.
por: Cosima Rhein, et al.
Publicado: (2012) -
Crystal structure of mammalian acid sphingomyelinase
por: Alexei Gorelik, et al.
Publicado: (2016) -
Prevalence of Cancer in Acid Sphingomyelinase Deficiency
por: Wladimir Mauhin, et al.
Publicado: (2021) -
Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase
por: Laura Monturiol‐Gross, et al.
Publicado: (2021)